๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

โœ Scribed by Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. M.; Morris, M.; Kantoff, P.; Monk, J. P.; Kaplan, E.

Book ID
111683956
Publisher
American Society of Clinical Oncology
Year
2012
Tongue
English
Weight
190 KB
Volume
30
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

705 ABIRATERONE ACETATE PLUS LOW-DOSE PR
705 ABIRATERONE ACETATE PLUS LOW-DOSE PREDNISONE HAS A FAVORABLE SAFETY PROFILE, IMPROVES SURVIVAL AND PRODUCES PSA AND RADIOGRAPHIC RESPONSES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER DOCETAXEL-BASED CHEMOTHERAPY: RESULTS FROM COU-AA-301, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY
โœ Saad, Fred; de Bono, Johann S.; Haqq, Christopher M.; Logothetis, Christopher J. ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Lippincott Williams and Wilkins ๐ŸŒ English โš– 56 KB
Final safety and efficacy analysis of th
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial
โœ Nicholas D. James; Armelle Caty; Heather Payne; Michael Borre; Bernard A. Zonnen ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 428 KB